Longitudinal analysis of insulin resistance and sarcopenic obesity in Chinese middle-aged and older adults: evidence from CHARLS
Frontiers in Public Health · 2024
DOI: 10.3389/fpubh.2024.1472456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, 2024. Verfasst von Chunyan Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Insulin Resistance, Obesity, Sarcopenia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Objective
The correlation between surrogate insulin resistance (IR) indices and sarcopenic obesity (SO) remains uncertain. This study aimed to assess the association between six IR surrogates—triglyceride-glucose (TyG), TyG-waist circumference (TyG-WC), TyG-waist-to-height ratio (TyG-WHtR), triglyceride-to-high-density lipoprotein-cholesterol ratio (TG/HDL), metabolic score for insulin resistance (METS-IR), and Chinese visceral adiposity index (CVAI)—and SO risk in a middle-aged and older population in China.
Methods
The study employed longitudinal data obtained from the China Health and Retirement Longitudinal Study (CHARLS) between 2011 and 2015, involving 6,395 participants. We used multivariate logistic regression models to examine the link between six surrogates and SO. Nonlinear relationships were evaluated using restricted cubic spline analysis, and subgroup analyses were conducted for validation. Receiver operating characteristic (ROC) curves were used to assess predictive capabilities.
Results
Over the course of a 4-year follow-up period, 319 participants (5.0%) developed SO. In the fully adjusted model, all six surrogates were significantly associated with SO. The adjusted odds ratios (ORs) with a 95% confidence interval (95% CI) per standard deviation increase were 1.21 (1.08–1.36) for TyG, 1.56 (1.39–1.75) for TyG-WC, 2.04 (1.81–2.31) for TyG-WHtR, 1.11 (1.01–1.21) for TG/HDL, 1.67 (1.50–1.87) for METS-IR, and 1.74 (1.55–1.97) for CVAI. Notably, TyG-WC, TyG-WHtR, TG/HDL, METS-IR, and CVAI exhibited nonlinear correlations with SO. Conversely, TG/HDL did not exhibit a significant association during subgroup analysis. Furthermore, TyG-WHtR had a significantly larger area under the receiver operating characteristic curve than other indices.
Conclusion
The results indicated that TyG, TyG-WC, TyG-WHtR, METS-IR, and CVAI were significantly and positively associated with SO incidence. Meanwhile, TyG-WC, TyG-WHtR, METS-IR, and CVAI showed nonlinear relationships with SO. Specifically, TyG-WHtR may be the most appropriate indicator for predicting SO among middle-aged and older Chinese adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- The Department of Geriatrics, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Faculty of Science, The University of Melbourne, Parkville, VIC, Australia.
Zitieren
APA
Xu, C., He, L., Tu, Y., Guo, C., Lai, H., Liao, C., Lin, C., & Tu, H. (2024). Longitudinal analysis of insulin resistance and sarcopenic obesity in Chinese middle-aged and older adults: evidence from CHARLS. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2024.1472456
Vancouver
Xu C, He L, Tu Y, Guo C, Lai H, Liao C, et al. Longitudinal analysis of insulin resistance and sarcopenic obesity in Chinese middle-aged and older adults: evidence from CHARLS. Frontiers in Public Health. 2024. doi:10.3389/fpubh.2024.1472456
BibTeX
@article{Xu2024,
author = {Xu, Chunyan and He, Ling and Tu, Yansong and Guo, Canhui and Lai, Hurong and Liao, Caifeng and Lin, Chuyang and Tu, Huaijun},
title = {Longitudinal analysis of insulin resistance and sarcopenic obesity in Chinese middle-aged and older adults: evidence from CHARLS},
journal = {Frontiers in Public Health},
year = {2024},
doi = {10.3389/fpubh.2024.1472456}
}
EUVIMED